Industry Focus

Spark Therapeutics, Rite Aid, and Alnylam shares have tumbled following news, but that doesn’t necessarily make all three stocks worth buying. Stocks: ONCE, RAD, ALNY

Direct download: 20180815_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

1